Low non‐relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle‐Thérapie Cellulaire observational study
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19163 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Laurent Garderet und 24 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hématologie, APHP, Hopital Pitié Salpêtrière, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Renal Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
High‐dose melphalan followed by autologous haematopoietic stem cell transplantation is widely used in newly diagnosed multiple myeloma (MM) patients as upfront therapy. However, the safety and efficacy of transplantation in patients with renal insufficiency (RI) are controversial. We followed a multicentre (16 SFGM‐TC centres) prospective cohort of 50 newly diagnosed MM patients with a serum creatinine clearance of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Hématologie, APHP, Hopital Pitié Salpêtrière, Sorbonne Université, Paris, France.
- Department of Hematology and Cell Therapy, EHU 1st Novembre 1954 Bir el Djir Usto, University Ahmed Benbella 1, Oran, Algeria.
- Département d'Hématologie Clinique et de Thérapie Cellulaire, CHU de Saint-Etienne, Saint-Etienne, France.
- Biostatistics Department, University of Paris, AP-HP, Saint Louis Hospital, Paris, France.
- Department of Hematology, Montpellier University Hospital, Montpellier, France.
- Hematology Department, Cochin Hospital, Paris, France.
ORCID-Profile: Laurent Garderet, Damien Roos-Weil, Pierre Morel
Zitieren
APA
Garderet, L., Ouldjeriouat, H., Bekadja, M. A., Daguenet, E., Bigot, N., Vincent, L., Roos-Weil, D., Vignon, M., Ikhlef, S., Abraham, J., Escoffre-Barbe, M., Lioure, B., Nacer, R. A., Lafon, I., Mariette, C., Karlin, L., Morel, P., Gilis, L., Le Ray, E., …, & Cornillon, J. (2024). Low non‐relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle‐Thérapie Cellulaire observational study. British Journal of Haematology. https://doi.org/10.1111/bjh.19163
Vancouver
Garderet L, Ouldjeriouat H, Bekadja MA, Daguenet E, Bigot N, Vincent L, et al. Low non‐relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle‐Thérapie Cellulaire observational study. British Journal of Haematology. 2024. doi:10.1111/bjh.19163
BibTeX
@article{Garderet2024,
author = {Garderet, Laurent and Ouldjeriouat, Hafida and Bekadja, Mohamed-Amine and Daguenet, Elisabeth and Bigot, Noemie and Vincent, Laure and Roos-Weil, Damien and Vignon, Marguerite and Ikhlef, Souhila and Abraham, Julie and Escoffre-Barbe, Martine and Lioure, Bruno and Nacer, Redhouane Ahmed and Lafon, Ingrid and Mariette, Clara and Karlin, Lionel and Morel, Pierre and Gilis, Lila and Le Ray, Emanuelle and Blouet, Anaïse and Nguyen Quoc, Stéphanie and Boffa, Jean Jacques and Ronco, Pierre and Lambert, Jerome and Cornillon, Jérôme},
title = {Low non‐relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle‐Thérapie Cellulaire observational study},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19163}
}
EUVIMED